Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2020 | Pages:
120 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global patient engagement solutions market size is expected to reach USD 41.7 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 17.3% over the forecast period. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment. In July 2019, a bipartisan group in Congress in U.S. introduced a new legislation that would allocate a fund of USD 25 million in grants for local, state, and tribal governments to develop Social Determinants Accelerator Plan with the aim to improve tracking and coordinating patient outcomes. Such initiatives are anticipated to drive the demand for these services over the forecast period. Moreover, in March 2019, the American Medical Association entered into a collaboration with PatientPoint with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using PatientPoint technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period. Some of the major market players are Allscripts Healthcare Solutions, Orion Health Ltd., Cerner Corporation, and McKesson Corporation, which collectively account for a substantial market share owing to their extensive product offerings. Moreover, key players are focusing on expanding their portfolio to gain competitive edge over their competitors. For instance, in October 2019, IQVIA launched Orchestrated Patient Engagement, a new cloud-based software as a service (SaaS) solution that narrows the gap between patients and life sciences companies by facilitating insights and interactions. Further key findings from the study suggest: • Web-based/cloud-based emerged as the largest delivery type segment in 2019 as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access • The software segment dominated the market in 2019, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions • Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years • Chronic diseases dominated the market in 2019 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data • North America dominated the global patient engagement solutions market in 2019 owing to increased adoption of m-health and electronic health record (EHR) and growing investments in patient engagement software by major companies • Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.11 Market Definition
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Patient Engagement Solutions Market Summary, 2019
Chapter 3 Patient Engagement Solutions Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping by Technology, 2019
3.3 User Perspective Analysis
3.3.1 Buyer’s Preference Analysis
3.3.2 Market Influencer Analysis
3.4 Regulatory Framework
3.4.1 Regulatory Landscape
3.5 Technology Overview
3.5.1 Patient engagement solutions: Adoption rate of changing technology
3.5.2 Timeline with major technology changes
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.2 Market Restraints Analysis
3.6.3 Industry Challenges
3.7 Industry Analysis - Porter’s
3.8 Patient Engagement Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Joint Ventures
3.9.2 Mergers & Acquisitions
3.9.3 Licensing & Partnership
3.9.4 Technology Collaborations
3.9.5 Strategic Divestments
3.10 Market Entry Strategies
Chapter 4 Patient Engagement Solutions Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.3 Key company market share analysis, 2019
4.4 Public Companies
4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2 Market Differentiators
4.4.3 Synergy Analysis: Major Deals & Strategic Alliances
4.5 Private Companies
4.5.1 List of key emerging companies’ /technology disruptors/innovators
4.5.2 Regional network map
4.6 Key customers
4.6.1 List of key buyers
4.7 Potential Target Audience
Chapter 5 Patient Engagement Solutions Market: Delivery Type Analysis
5.1 Delivery Type Business Analysis
5.1.1 Web/Cloud-Based
5.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
5.1.2 On-Premise
5.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 6 Patient Engagement Solutions Market: Component
6.1 Component Analysis
6.1.1 Software
6.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.2 Standalone
6.1.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.1.3 Integrated
6.1.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2 Services
6.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.2 Consulting Services
6.1.2.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.3 Implementation services
6.1.2.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.4 Education services
6.1.2.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.2.5 Other services
6.1.2.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
6.1.3 Hardware
6.1.3.1 Hardware market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 7 Patient Engagement Solutions Market: End-Use
7.1 End-Use Analysis
7.1.1 Payers
7.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
7.1.2 Providers
7.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
7.1.3 Individual Users
7.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Patient Engagement Solutions Market: Application
8.1 Application Analysis
8.1.1 Social Management
8.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.1.2 Health Management
8.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.1.3 Home Healthcare Management
8.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
8.1.4 Financial Health Management
8.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 9 Patient Engagement Solutions Market: Therapeutic Area
9.1 Application Analysis
9.1.1 Chronic Diseases
9.1.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.1.2 Obesity
9.1.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.1.3 Diabetes
9.1.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.1.4 Cardiovascular
9.1.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.1.5 Others
9.1.1.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.2 Fitness
9.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.3 Women's Health
9.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.4 Mental Health
9.1.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
9.1.5 Others
9.1.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 10 Patient Engagement Solutions: Regional Market Analysis, By Application, Technology, and End Use 2016 - 2027 (USD Million)
10.1 Regional Market Share Analysis, 2019 & 2027
10.2 Regional Market Dashboard
10.3 Regional Market Snapshot
10.4 Market Size, & Forecasts and Trend Analysis, 2019 to 2027
10.4.1 North America
10.4.1.1 Market estimates and segment forecasts, 2016 - 2027 (USD Million)
10.4.1.2 U.S.
10.4.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.1.3 Canada
10.4.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2 Europe
10.4.2.1 Market estimates And Forecasts By Countries, 2016 - 2027 (USD Million)
10.4.2.2 U.K.
10.4.2.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.3 Germany
10.4.2.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.4 France
10.4.2.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.5 Italy
10.4.2.5.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.6 Spain
10.4.2.6.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.7 Netherlands
10.4.2.7.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.2.8 Sweden
10.4.2.8.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.3 Asia Pacific
10.4.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.3.2 Japan
10.4.3.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.3.3 China
10.4.3.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.4.3.4 India
10.4.3.4.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.5.1 Latin America
10.5.1.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.5.1.2 Brazil
10.5.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.5.1.3 Mexico
10.5.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.1 MEA
10.6.1.1 Market estimates and forecasts by countries, 2016 - 2027 (USD Million)
10.6.1.2 South Africa
10.6.1.2.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
10.6.1.3 Saudi Arabia
10.6.1.3.1 Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 11 Company Profiles
11.1 Allscripts Healthcare Solutions
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 McKesson Corporation
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 Orion Health Ltd.
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Cerner Corporation
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Phytel Inc.
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Medecision Inc.
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 GetWellNetwork Inc.
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 YourCareUniverse Inc.
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.8.4 Strategic Initiatives
11.9 Lincor Solutions Ltd.
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Athenahealth, Inc.
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
List of Tables Table 1 List of secondary sources Table 2 List of key emerging companies Table 3 Patient Engagement Solutions - Industry Snapshot Table 4 Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 5 Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 6 Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 7 Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 8 Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 9 Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 10 Patient Engagement Solutions Market - Key Market driver’s analysis Table 11 Patient Engagement Solutions Market - Key Market restraints analysis Table 12 North America Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 13 North America Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 14 North America Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 15 North America Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 16 North America Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 17 North America Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 18 U.S. Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 19 U.S. Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 20 U.S. Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 21 U.S. Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 22 U.S. Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 23 Canada Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 24 Canada Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 25 Canada Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 26 Canada Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 27 Canada Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 28 Europe Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 29 Europe Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 30 Europe Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 31 Europe Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 32 Europe Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 33 Europe Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 34 U.K. Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 35 U.K. Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 36 U.K. Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 37 U.K. Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 38 U.K. Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 39 Germany Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 40 Germany Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 41 Germany Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 42 Germany Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 43 Germany Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 44 France Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 45 France Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 46 France Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 47 France Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 48 France Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 49 Italy Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 50 Italy Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 51 Italy Patient Engagement Solutions Market, by End Use, 2016 to 2027 (USD Million) Table 52 Italy Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 53 Italy Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 54 Spain Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 55 Spain Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 56 Spain Patient Engagement Solutions Market, by End Use, 2016 to 2027 (USD Million) Table 57 Spain Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 58 Spain Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 59 Netherlands Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 60 Netherlands Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 61 Netherlands Patient Engagement Solutions Market, by End Use, 2016 to 2027 (USD Million) Table 62 Netherlands Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 63 Netherlands Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 64 Sweden Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 65 Sweden Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 66 Sweden Patient Engagement Solutions Market, by End Use, 2016 to 2027 (USD Million) Table 67 Sweden Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 68 Sweden Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 69 Russia Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 70 Russia Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 71 Russia Patient Engagement Solutions Market, by End Use, 2016 to 2027 (USD Million) Table 72 Russia Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 73 Spa Russia in Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 74 Asia Pacific Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 75 Asia Pacific Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 76 Asia Pacific Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 77 Asia Pacific Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 78 Asia Pacific Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 79 Asia Pacific Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 80 Japan Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 81 Japan Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 82 Japan Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 83 Japan Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 84 Japan Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 85 China Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 86 China Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 87 China Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 88 China Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 89 China Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 90 India Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 91 India Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 92 India Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 93 India Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 94 India Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 95 Latin America Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 96 Latin America Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 97 Latin America Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 98 Latin America Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 99 Latin America Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 100 Latin America Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 101 Brazil Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 102 Brazil Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 103 Brazil Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 104 Brazil Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 105 Brazil Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 106 Mexico Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 107 Mexico Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 108 Mexico Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 109 Mexico Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 110 Mexico Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 111 MEA Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 112 MEA Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 113 MEA Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 114 MEA Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 115 MEA Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 116 MEA Patient Engagement Solutions Market, by Region, 2016 to 2027 (USD Million) Table 117 South Africa Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 118 South Africa Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 119 South Africa Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 120 South Africa Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 121 South Africa Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Table 122 Saudi Arabia Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Table 123 Saudi Arabia Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Table 124 Saudi Arabia Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Table 125 Saudi Arabia Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Table 126 Saudi Arabia Patient Engagement Solutions Market, by Therapeutic Area (USD Million) List of Figures Fig. 1 Patient Engagement Solutions Market Segmentation Fig. 2 Global Patient Engagement Solutions Market Revenue, 2016 - 2027 Fig. 3 Patient Engagement Solutions Market Dynamics Fig. 4 Key Opportunities Prioritized Fig. 5 Patient Engagement Solutions Market Analysis - Porter's Fig. 6 Patient Engagement Solutions Market Analysis - PESTEL Analysis Fig. 7 Global Patient Engagement Solutions Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 8 Global Patient Engagement Solutions Market, by Component, 2016 to 2027 (USD Million) Fig. 9 Global Patient Engagement Solutions Market, by End-Use, 2016 to 2027 (USD Million) Fig. 10 Global Patient Engagement Solutions Market, by Application, 2016 to 2027 (USD Million) Fig. 11 Global Patient Engagement Solutions Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 12 Delivery Type Market, 2016 to 2027 (USD Million) Fig. 13 Web/Cloud-Based Delivery Market, 2016 to 2027 (USD Million) Fig. 14 On-premise Delivery Market, 2016 to 2027 (USD Million) Fig. 15 Component Market, 2016 to 2027 (USD Million) Fig. 16 Software Market, 2016 to 2027 (USD Million) Fig. 17 Services Market, 2016 to 2027 (USD Million) Fig. 18 Hardware Market, 2016 to 2027 (USD Million) Fig. 19 End-Use Market, 2016 to 2027 (USD Million) Fig. 20 Payers Market, 2016 to 2027 (USD Million) Fig. 21 Providers Market, 2016 to 2027 (USD Million) Fig. 22 Individual users Market, 2016 to 2027 (USD Million) Fig. 23 Application Market, 2016 to 2027 (USD Million) Fig. 24 Social Management Market, 2016 to 2027 (USD Million) Fig. 25 Health Management Market, 2016 to 2027 (USD Million) Fig. 26 Home Healthcare Management Market, 2016 to 2027 (USD Million) Fig. 27 Financial Health Management Market, 2016 to 2027 (USD Million) Fig. 28 Therapeutic Area Market, 2016 to 2027 (USD Million) Fig. 29 Chronic Diseases Market, 2016 to 2027 (USD Million) Fig. 30 Women’s Health Market, 2016 to 2027 (USD Million) Fig. 31 Fitness Market, 2016 to 2027 (USD Million) Fig. 32 Mental Health Market, 2016 to 2027 (USD Million) Fig. 33 Others Market, 2016 to 2027 (USD Million) Fig. 34 Global Patient Engagement Solutions Market, by region 2016 to 2027 (USD Million) Fig. 35 North America Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 36 North America Market, by Component, 2016 to 2027 (USD Million) Fig. 37 North America Market, by End-Use, 2016 to 2027 (USD Million) Fig. 38 North America Market, by Application, 2016 to 2027 (USD Million) Fig. 39 North America Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 40 U.S. Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 41 U.S. Market, by Component, 2016 to 2027 (USD Million) Fig. 42 U.S. Market, by End-Use, 2016 to 2027 (USD Million) Fig. 43 U.S. Market, by Application, 2016 to 2027 (USD Million) Fig. 44 U.S. Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 45 Canada Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 46 Canada Market, by Component, 2016 to 2027 (USD Million) Fig. 47 Canada Market, by End-Use, 2016 to 2027 (USD Million) Fig. 48 Canada Market, by Application, 2016 to 2027 (USD Million) Fig. 49 Canada Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 50 Europe Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 51 Europe Market, by Component, 2016 to 2027 (USD Million) Fig. 52 Europe Market, by End-Use, 2016 to 2027 (USD Million) Fig. 53 Europe Market, by Application, 2016 to 2027 (USD Million) Fig. 54 Europe Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 55 U.K. Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 56 U.K. Market, by Component, 2016 to 2027 (USD Million) Fig. 57 U.K. Market, by End-Use, 2016 to 2027 (USD Million) Fig. 58 U.K. Market, by Application, 2016 to 2027 (USD Million) Fig. 59 U.K. Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 60 Germany Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 61 Germany Market, by Component, 2016 to 2027 (USD Million) Fig. 62 Germany Market, by End-Use, 2016 to 2027 (USD Million) Fig. 63 Germany Market, by Application, 2016 to 2027 (USD Million) Fig. 64 Germany Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 65 Spain Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 66 Spain Market, by Component, 2016 to 2027 (USD Million) Fig. 67 Spain Market, by End-Use, 2016 to 2027 (USD Million) Fig. 68 Spain Market, by Application, 2016 to 2027 (USD Million) Fig. 69 Spain Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 70 France Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 71 France Market, by Component, 2016 to 2027 (USD Million) Fig. 72 France Market, by End-Use, 2016 to 2027 (USD Million) Fig. 73 France Market, by Application, 2016 to 2027 (USD Million) Fig. 74 France Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 75 Italy Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 76 Italy Market, by Component, 2016 to 2027 (USD Million) Fig. 77 Italy Market, by End-Use, 2016 to 2027 (USD Million) Fig. 78 Italy Market, by Application, 2016 to 2027 (USD Million) Fig. 79 Italy Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 80 Sweden Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 81 Sweden Market, by Component, 2016 to 2027 (USD Million) Fig. 82 Sweden Market, by End-Use, 2016 to 2027 (USD Million) Fig. 83 Sweden Market, by Application, 2016 to 2027 (USD Million) Fig. 84 Sweden Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 85 Netherlands Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 86 Netherlands Market, by Component, 2016 to 2027 (USD Million) Fig. 87 Netherlands Market, by End-Use, 2016 to 2027 (USD Million) Fig. 88 Netherlands Market, by Application, 2016 to 2027 (USD Million) Fig. 89 Netherlands Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 90 Russia Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 91 Russia Market, by Component, 2016 to 2027 (USD Million) Fig. 92 Russia Market, by End-Use, 2016 to 2027 (USD Million) Fig. 93 Russia Market, by Application, 2016 to 2027 (USD Million) Fig. 94 Russia Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 95 APAC Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 96 APAC Market, by Component, 2016 to 2027 (USD Million) Fig. 97 APAC Market, by End-Use, 2016 to 2027 (USD Million) Fig. 98 APAC Market, by Application, 2016 to 2027 (USD Million) Fig. 99 APAC Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 100 China Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 101 China Market, by Component, 2016 to 2027 (USD Million) Fig. 102 China Market, by End-Use, 2016 to 2027 (USD Million) Fig. 103 China Market, by Application, 2016 to 2027 (USD Million) Fig. 104 China Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 105 Japan Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 106 Japan Market, by Component, 2016 to 2027 (USD Million) Fig. 107 Japan Market, by End-Use, 2016 to 2027 (USD Million) Fig. 108 Japan Market, by Application, 2016 to 2027 (USD Million) Fig. 109 Japan Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 110 India Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 111 India Market, by Component, 2016 to 2027 (USD Million) Fig. 112 India Market, by End-Use, 2016 to 2027 (USD Million) Fig. 113 India Market, by Application, 2016 to 2027 (USD Million) Fig. 114 India Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 115 Latin America Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 116 Latin America Market, by Component, 2016 to 2027 (USD Million) Fig. 117 Latin America Market, by End-Use, 2016 to 2027 (USD Million) Fig. 118 Latin America Market, by Application, 2016 to 2027 (USD Million) Fig. 119 Latin America Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 120 Mexico Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 121 Mexico Market, by Component, 2016 to 2027 (USD Million) Fig. 122 Mexico Market, by End-Use, 2016 to 2027 (USD Million) Fig. 123 Mexico Market, by Application, 2016 to 2027 (USD Million) Fig. 124 Mexico Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 125 Brazil Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 126 Brazil Market, by Component, 2016 to 2027 (USD Million) Fig. 127 Brazil Market, by End-Use, 2016 to 2027 (USD Million) Fig. 128 Brazil Market, by Application, 2016 to 2027 (USD Million) Fig. 129 Brazil Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 130 MEA Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 131 MEA Market, by Component, 2016 to 2027 (USD Million) Fig. 132 MEA Market, by End-Use, 2016 to 2027 (USD Million) Fig. 133 MEA Market, by Application, 2016 to 2027 (USD Million) Fig. 134 MEA Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 135 South Africa Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 136 South Africa Market, by Component, 2016 to 2027 (USD Million) Fig. 137 South Africa Market, by End-Use, 2016 to 2027 (USD Million) Fig. 138 South Africa Market, by Application, 2016 to 2027 (USD Million) Fig. 139 South Africa Market, by Therapeutic Area, 2016 to 2027 (USD Million) Fig. 140 Saudi Arabia Market, by Delivery Type, 2016 to 2027 (USD Million) Fig. 141 Saudi Arabia Market, by Component, 2016 to 2027 (USD Million) Fig. 142 Saudi Arabia Market, by End-Use, 2016 to 2027 (USD Million) Fig. 143 Saudi Arabia Market, by Application, 2016 to 2027 (USD Million) Fig. 144 Saudi Arabia Market, by Therapeutic Area, 2016 to 2027 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
